Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hemojuvelin is a protein encoded by the *HJV* gene, primarily expressed in the liver, heart, and skeletal muscle. It exists in both membrane-bound and soluble forms and plays a central role in systemic iron homeostasis by regulating the expression of hepcidin, a key hormone for maintaining iron balance. It acts as a co-receptor for bone morphogenetic proteins (BMPs), activating hepcidin transcription through the BMP/SMAD signaling pathway. Mutations in *HJV* are most commonly associated with juvenile-onset hereditary hemochromatosis, characterized by excessive dietary iron absorption leading to tissue damage from iron overload.
Modulation of hepcidin expression via BMP/SMAD signaling pathway
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemojuvelin (HJV).